Stelios Therapeutics

Stelios Therapeutics is an early-stage company developing novel AAV-based gene therapies for rare inherited cardiovascular diseases. The company was founded based on research conducted at the University of California San Diego (UCSD) by a distinguished team of researchers and scientists with extensive experience and expertise in gene therapy drug development.